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Several Borrelia burgdorferi genes induced under mammalian host conditions have been purported to be impor-
tant in Lyme disease pathogenesis based on their binding to host structures. These genes include the dbpBA locus,
whose products bind host decorin and glycosoaminoglycans. Recently, the dbpBA genes were reported to be involved
in borrelial infectivity. Here we extended the previous observations by using culture and quantitative PCR to
evaluate low- and high-dose murine infection by adbpBA::Gentr derivative of B. burgdorferi strain B31. The results
indicate that the dbpBA::Gentr mutant is attenuated in the ability to initially colonize and then persist in multiple
tissues. The mutant exhibited a colonization defect as early as 3 days postinfection, before the development of an
adaptive immune response, and after low-dose infection of SCID mice, which are deficient in adaptive immunity.
These findings suggest that the inability to adhere to host decorin may promote clearance of B. burgdorferi,
presumably via innate immune mechanisms. In a high-dose infection, the mutant disseminated to several tissues,
particularly joint tissue, but it was generally cleared from these tissues by 3 weeks postinfection. Finally, following
high-dose infection of SCID mice, the dbpBA mutant exhibited only a mild colonization defect, suggesting that the
adaptive response is involved in the clearance of the mutant in immunocompetent mice. Taken together, these
results suggest that the DbpBA proteins facilitate the colonization of multiple tissues by B. burgdorferi and are
required for optimal resistance to both innate and adaptive immune mechanisms following needle inoculation.
Borrelia burgdorferi is the etiologic agent of Lyme disease
and traffics within an enzootic cycle that involves an arthropod
vector and rodent mammalian reservoirs, but it can also infect
other mammalian species, including humans. In humans, the
bite of an infected Ixodes tick usually results in a red skin
lesion, designated erythema migrans, and the illness is accom-
panied by general malaise and, in some cases, cardiac and
neurologic sequela (for reviews, see references 39 and 58).
Individuals who do not seek antibiotic therapy at this stage of
the infection are at risk for developing manifestations associ-
ated with late Lyme disease, which in the United States are
usually arthritis. In Europe, a neurologic pathology and an
inflammatory skin condition known as acrodermatitis chronica
atrophicans can occur in chronically infected individuals. As
such, in areas where it is endemic, Lyme disease contributes to
significant morbidity.
By virtue of its ability to transition between ticks and mam-
mals, B. burgdorferi must modify gene expression quickly to
adapt to such disparate environments. Previous studies using
transcriptional profiling demonstrated that B. burgdorferi gene
expression changes in response to pH, temperature, redox sta-
tus, exposure to blood, and as-yet-uncharacterized mammal-
specific factors (1, 2, 5, 10, 11, 15, 17, 26, 36, 40, 48, 51, 52, 59,
60, 63). One set of genes transcribed under conditions that
mimic host-adapted conditions (either increased temperature,
lower pH, redox status, or blood exposure) includes the dbpA
and dbpB genes (5, 26, 40, 48, 52, 60), which are apparently
cotranscribed from dbpB to dbpA (i.e., dbpBA) (22) and en-
code adhesins that bind to mammalian decorin (20, 21).
Decorin is abundant in the extracellular matrix (ECM) of the
dermal skin layer, as well as in joint tissue (7, 34, 43). The
induction of dbpBA under simulated host conditions is consis-
tent with the hypothesis that these genes have a role in borre-
lial pathogenesis, and the DbpBA proteins, along with other
adhesins, are presumed to assist in cell and ECM attachment
of B. burgdorferi to mediate colonization and initiate dissemi-
nation within the mammalian host (7, 20, 21, 34). To investi-
gate this hypothesis, the dbpBA genes were deleted, and the
resulting mutant was tested using BALB/c mice (56). In their
initial study, Shi et al. concluded that DbpA and DbpB were
not essential for mouse infection, although only 58% of the
tissues were culture positive when a single large inoculum (105
B. burgdorferi cells) was used and no genetic complementation
of intact dbpBA was evaluated (56). Another study indicated
that the constitutive overexpression of dbpBA makes B. burg-
dorferi more infectious but impairs its ability to disseminate,
suggesting that DbpBA has an important role in experimental
infections (62). A more recent study by Shi et al. indicated that
the dbpBA genes are required for virulence in mice following
needle inoculation (55), a finding that was corroborated re-
* Corresponding author. Mailing address: 407 Reynolds Medical
Building, Department of Microbial and Molecular Pathogenesis, Texas
A&M Health Science Center, College Station, TX 77843. Phone: (979)
845-1376. Fax: (979) 845-3479. E-mail: jskare@medicine.tamhsc.edu.
 Published ahead of print on 22 September 2008.
5694
 o
n
 Septem
ber 21, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
cently by Blevins et al. (4). Due to the differences in the studies
mentioned above, the role of DbpBA in borrelial pathogenesis
was independently evaluated and extended in the current
study.
In this report, we demonstrate that deletion of dbpBA results
in marked attenuation of B. burgdorferi in immunocompetent
C3H mice following needle inoculation and we suggest that
binding to host decorin early in the infectious process may be
important in preventing clearance of B. burgdorferi via the
innate immune response. The ability of the dbpBA mutant to
colonize immunodeficient mice at a high-dose inoculum with
which immunocompetent mice are effectively not infected sug-
gests that, in addition to the early defect in survival observed,
adaptive immunity further reduces the numbers of dbpBA mu-
tant cells. These results suggest that binding to decorin within
the ECM represents an important early step in the coloniza-
tion of B. burgdorferi that promotes the establishment and
persistence of this spirochete during experimental infection.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. All bacterial strains and
plasmids used in this study are listed in Table 1. All B. burgdorferi strains were
grown in complete BSK-II medium as described previously (57). For selective
pressure, B. burgdorferi was grown in BSK-II medium with antibiotics, where
appropriate, at the following concentrations: kanamycin, 300 g/ml; streptomy-
cin, 50 g/ml; and gentamicin, 50 g/ml. All Escherichia coli strains were grown
with aeration in LB media at 37°C. For experiments involving E. coli, antibiotics
were used at the following concentrations: carbenicillin, 100 g/ml; ampicillin,
100 g/ml; spectinomycin, 100 g/ml; gentamicin, 5 g/ml; chloramphenicol, 15
g/ml; and kanamycin, 50 g/ml.
PCR. A PCR was conducted using either Herculase polymerase (Stratagene,
La Jolla, CA) or Taq polymerase (Supermix; Invitrogen, Carlsbad, CA) as pre-
viously described (26, 52, 54). The oligonucleotide primers used in this study are
listed in Table 2.
Construction of the dbpBA::Gentr plasmid. To delete the dbpBA operon in B.
burgdorferi, a 1.7-kb fragment that included the 3 end of dbpA (BBA24) and
sequences downstream, including part of BBA21, was amplified using the
BBA21F and dbpAsalmut primers and borrelial genomic DNA as the template
(Table 2). Next, a 2.8-kb fragment containing the start of dbpB (BBA25) and its
upstream region, including a portion of BBA36, was amplified similarly using the
BBA31com and dbpBsalmut primers (Table 2). Both fragments were cloned
separately into the TA cloning vector pCR-XL-TOPO (Invitrogen), and trans-
formants were selected for with kanamycin. After the sequences of the 1.7- and
2.8-kb fragments were confirmed, the 1.7-kb BBA21-dbpA-SalI fragment was
purified following digestion with BamHI and SalI. The resulting product was
then cloned into the SalI-BBA31-dbpB SalI fragment construct mentioned above
that also was digested with BamHI and SalI. The resulting construct was missing
most of the dbpB and dbpA sequences, and a single unique SalI site was gener-
ated in place of these sequences. The gentamicin resistance cassette was ampli-
fied using pBVS2G (generously provided by Patricia Rosa [16]) as the template,
which contained the aacC1 gentamicin resistance (Gentr) gene linked to the
strong borrelial flgB promoter, using 5flgGentsal and 3flgGentsal as the primers
(Table 2). The resulting amplified product was TA cloned into the pCR-XL-
TOPO vector, and E. coli transformants were selected based on coresistance to
kanamycin and gentamicin. The resulting clone was sequenced, digested with
SalI, and cloned into the unique SalI site engineered in the dbpBA deletion
construct. E. coli transformants containing the Gentr dbpBA deletion construct
were selected based on coresistance to kanamycin and gentamicin. The final
construct containing the PflgB-Gentr cassette in place of dbpBA (dbpBA::Gentr)
was screened by digestion with SalI, confirmed by sequencing, and subsequently
designated pNP3.
Gateway vector-borrelial shuttle vector construction. To isolate a borrelial
shuttle vector that could be easily modified using Invitrogen’s Gateway recom-
bination-based cloning system, the attR1-Camr-ccdB-attR2 region from
pDEST17 (Invitrogen) that confers resistance to chloramphenicol was PCR
amplified with SphI linkers using oligonucleotide primers ATTR1F and
ATTR1R (Table 2). The amplified product was cloned into pCR2.1-TOPO
(Invitrogen) and transformed into ccdB survival T1R cells. The resulting con-
struct was digested with SphI, and the SphI-attR1-Camr-ccdB-attR2-SphI-con-
taining fragment was cloned into pBBE22 (generously provided by Steve Norris
[46]) cut with SphI, ligated, and transformed into ccdB survival T1R cells (In-
vitrogen). Transformants were selected with kanamycin and chloramphenicol,
TABLE 1. Strains and plasmids used in this study
Strain or plasmid Genotype or characteristics Reference(s) orsource
B. burgdorferi strains
ML23 Missing lp25 30, 31
ML23/pBBE22 Missing lp25, complemented with BBE22 54
JF105 ML23 dbpBA::Gentr This study
JF105/pBBE22 ML23 dbpBA::Gentr, complemented with BBE22 This study
JF105/pJBF17 ML23 dbpBA::Gentr, complemented with BBE22 and dbpBA This study
E. coli strains
DH5 F 80lacZM15 (lacZYA-argF)U169 recA1 endA1 hsdR17(rK
 mK
) supE44 thi-1
gyrA96 relA1 
Invitrogen
ccdB survival T1R F mcrA (mrr-hsdRMS-mcrBC) 80lacZM15 lacX74 recA1 araD139 (ara-leu)7697
galU galK rpsL (Strr) endA1 nupG tonA::Ptrc-ccdA
Invitrogen
Plasmids
pCR2.1-TOPO Ampr Kanr; PCR cloning vector Invitrogen
pCR-XL-TOPO Kanr; PCR cloning vector Invitrogen
pCR8/GW/TOPO Spcr; Gateway PCR cloning/entry vector Invitrogen
pDEST17 Camr Ampr; Gateway destination vector Invitrogen
pBSV2G Gentr; borrelial shuttle vector 16
pBBE22 Kanr; borrelial shuttle vector carrying BBE22 46
pBBE22gate Camr Kanr; pBBE22 modified to be a Gateway destination vector containing attR sitesa This study
pNP3 Gentr Kanr; dbpBA::Gentr construct containing region of lp54 that contains 1.5 kb
upstream and downstream of the end of dbpA (BBA24) and the start of dbpB
(BBA25)
This study
pJBF12 Spcr; intact dbpBA cloned into pCR8/GW/TOPO flanked by attL sites This study
pJBF17 Kanr; intact dbpBA recombined via Gateway system into pBBE22gate This study
a See Materials and Methods.
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and the resulting plasmid construct was designated pBBE22gate. Subsequently,
the dbpBA genes with 289 bp upstream and 131 bp downstream of the open
reading frame was PCR amplified with oligonucleotide primers DbpBA-F-
XmaNco and DbpBA-R-XmaNde (Table 2), and the resulting 1,689-bp band was
cloned into the entry vector pCR8/GW/TOPO (Spcr; Invitrogen) that contains
attL sites that flank the inserted fragment. Clones that conferred resistance to
spectinomycin were screened, and the desired construct was designated pJBF12.
An LR reaction, which involved the LR recombinase that promotes recombina-
tion with constructs containing attL and attR sites, was performed with pJBF12
and pBBE22gate, respectively, by using the manufacturer’s specifications, except
that both plasmids were incubated at 55°C for 10 min to relax supercoiling prior
to addition of the LR recombinase. The LR reaction mixture was then incubated
at 25°C for 1 h and then overnight at 15°C. Then the LR reaction mixture was
transformed into DH5 cells, and transformants were selected with kanamycin
and screened for sensitivity to chloramphenicol. The resulting plasmid with
dbpBA recombined into pBBE22gate (resulting in concomitant loss of Camr and
ccdB) was designated pJBF17.
Genetic manipulation of B. burgdorferi. The B. burgdorferi strain B31 derivative
ML23 (Table 1) was made electrocompetent as previously described (54) and
transformed with pNP3 that contained the dbpBA::Gentr construct. Transfor-
mants were selected by limiting dilution in liquid BSK-II containing gentamicin
using 96-well plates as described previously (64) to obtain strain JF105 (ML23
dbpBA::Gentr) (Table 1). Strain JF105 was then made electrocompetent and
transformed with either pBBE22 (Kanr) to complement the infectivity defect
inherent in the lp25-deficient ML23 strain background or with pJBF17 (Kanr) to
complement the infectivity defect and provide intact dbpBA (Table 1).
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblot
analysis. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immu-
noblot analyses were performed as previously described (26, 52–54). Antiserum
to DbpA was used in conjunction with appropriate substrates for chemilumines-
cent detection as described previously (26, 52–54).
Mouse infectivity: ID50 analysis. The 50% infective doses (ID50) of ML23/
pBBE22, JF105/pBBE22 (dbpBA::Gentr), and JF105/pJBF17 were determined
as previously described (31, 54). C3H/HeN mice were infected for 21 days,
sacrificed, and processed to determine whether organs (skin at the site on
inoculation, spleen, heart, bladder, lymph nodes, and tibiotarsal joint) were
colonized by examining growth in BSK-II medium for 1 month after the animals
were sacrificed. Each of the infectivity experiments was conducted two separate
times over a 5-month period to assess reproducibility.
Mouse infectivity: kinetics-based analysis. C3H/HeN mice were infected in-
tradermally with either 103 or 105 cells of ML23/pBBE22, JF105/pBBE22
(dbpBA::Gentr), or JF105/pJBF17, and 12 h later the mice were sacrificed and
skin samples from the site of inoculation were cultured in BSK-II medium (31,
54). Additional kinetics-based infectivity analyses were conducted essentially as
described above on days 3, 5, 7, 14, and 21 (30). Groups of mice were infected
using inocula containing 103 and 105 cells for each B. burgdorferi strain tested
(except ML23/pBBE22, for which only an inoculum containing 103 cells was
used) in two separate infectivity experiments. Following sacrifice at the time
points indicated above, the tissues described above for the ID50 analysis were
removed and cultured in BSK-II medium.
Mouse infectivity: SCID mouse infectivity. C3H-SCID mice (Harlan Labora-
tories, Philadelphia, PA) were infected with 103 and 105 cells of ML23/pBBE22,
JF105/pBBE22 (dbpBA::Gentr), and JF105/pJBF17 as previously described
(30), except that the mice were sacrificed after 21 days.
Extraction of DNA from tissue for quantitative PCR analysis. Joint and skin
samples were aseptically removed and placed in 200 l of cold phosphate-
buffered saline. Total genomic DNA was extracted using a Roche High Pure
PCR template preparation kit as described previously (37) except that a 2%
TABLE 2. Oligonucleotides used in this study
Oligonucleotide Sequence (5–3) Description
BBA21F GATAAATAAAAGAAATTTATCTGAAA Primer pair that amplifies a 1.7-kb fragment containing
dbpAsalmut ACGCGTCGACATCCTTCTTTTACTGATGA bba21 to sequences downstream of bba24 (dbpA)
BBA31com CGCATTTGCAAGAGAATCAAGCGCATCGTCTT Primer pair that amplifies a 2.8-kb fragment containing
dbpBsalmut ACGCGTCGACCAAGACCATAACTATTGAATT bba31 to sequences upstream of bba25 (dbpB)
5pflgGentSal ACGCGTCGACGAACGAATTGTTAGGTGGCGGTACT Primer pair that amplifies a 0.9-kb fragment containing
3pflgGentSal ACGCGTCGACCCCGAGCTTCAAGGAAGATTTCCT the aacC1 allele (Gentr) fused to the borrelial flgB
promoter (PflgB-Gent
r) in the dbpBA::Gentr mutant
only
5ABMut TTTATGTCTTGATTATCGGGCGAAGAGTTTA When used with 3ABMut, amplifies 1.6- and 1.4-kb
bands in the parent and dbpBA::Gentr mutant,
respectively; when used with 5pflgGentSal, amplifies
a 1.1-kb fragment in the dbpBA::Gentr mutant only
3ABMut AAGCCAGATTGCATAGCAAGCTTGAATTCCAA When used with 3pflgGentSal, amplifies a 1.2-kb
fragment in the dbpBA::Gentr mutant only
ATTR1F GCATGCCCTCGAATCAACAAGTTTG Primer pair used to amplify the attR1-Camr-ccdB-
ATTR1R GCATGCCGCAGCCTCGAATCAACCAC attR2 region from pDEST17 for cloning into
borrelial shuttle vectors to convert them to Gateway
amenable vectors
DbpBA-F-XmaNco CCCGGGCCATGGCTTGATTATCGGGCGAAGAG Primer pair that amplifies a 1.7-kb fragment containing
DbpBA-R-XmaNde CCCGGGCATATGGCAAACTGGAAACAAGTC the intact dbpBA locus with 289 bp upstream and
131 bp downstream for cloning into
pCR8/GW/TOPO
nTM17FrecA GTGGATCTATTGTATTAGATGAGGCTCTCG Primer pair used for real-time quantitative PCR
nTM17RrecA GCCAAAGTTCTGCAACATTAACACCTAAAG detection of B. burgdorferi recA genea
bactinF CAAGTCATCACTATTGGCAACGA Primer pair used for real-time quantitative PCR
bactinR CCAAGAAGGAAGGCTGGAAAA detection of the murine 	-actin geneb
a See reference 35.
b See reference 37.
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collagenase solution (Sigma Aldrich) was added prior to the overnight incuba-
tion at 55°C.
Quantification of B. burgdorferi in infected tissues. B. burgdorferi genomic
equivalents in infected tissues were enumerated using an Applied Biosystems
ABI 7500 fast real-time PCR system (Applied Biosystems Corp., Foster City,
CA) in conjunction with Sybr green PCR Mastermix (Applied Biosystems).
Approximately 100 ng of DNA was added to each reaction mixture. B. burgdorferi
genome copies were detected using oligonucleotide primers nTM17FrecA and
nTM17RrecA (Table 2) (35) at a final concentration of 0.3 M to specifically
detect the B. burgdorferi recA gene. The numbers of borrelial genomic copies
were calculated by comparing the threshold cycle (CT) values with the values for
serial dilutions of known amounts of B. burgdorferi genomic DNA, which were
used as standards. Mouse genomic copies were detected using oligonucleotide
primers bactinF and bactinR, which are specific for the mouse 	-actin gene, at a
final concentration of 0.3 M. The numbers of 	-actin copies were calculated by
comparing the CT values with the values for serial dilutions of known amounts of
the 	-actin gene, which were used as standards (37). Triplicate measurements
were obtained for all samples, and the values shown below are the numbers of B.
burgdorferi recA copies per 106 mouse 	-actin copies.
Statistical analysis. Quantitative PCR data were compared by transforming
the number of B. burgdorferi genome copies (Nc) (normalized using 106 copies of
mouse 	-actin) to log10(Nc  0.1) prior to one-factor (see Fig. 2) or two-factor
(see Fig. 3A and 3B) analysis of variance. Parent, mutant, and complement copy
numbers were compared by constructing appropriate orthogonal contrasts using
the analysis of variance model coefficients. Calculations were performed using
S-PLUS 7 for Windows (Insightful Corporation, Seattle, WA).
RESULTS
Isolation of dbpBA::Gentr mutant of B. burgdorferi. To
isolate a dbpBA deletion in B. burgdorferi, the region of the
54-kb linear plasmid (lp54) that encodes dbpBA (BBA24
[dbpA] and BBA25 [dbpB]) was amplified by PCR such that the
genes were eliminated and a unique restriction site was gen-
erated simultaneously. Subsequently, a borrelial promoter-
gentamicin resistance cassette was cloned into the engineered
site to generate the dbpBA::Gentr construct pNP3 (Fig. 1A).
In order to isolate a dbpBA::Gentr strain, pNP3 was trans-
formed into strain ML23, which lacks the 25-kb linear plasmid
(lp25) and, due to the absence of a restriction/modification
system, is more readily transformable (54). Gentamicin-resis-
tant isolates were obtained and analyzed by PCR (Fig. 1B) and
Southern blotting (data not shown) to confirm the desired
deletion. PCR analysis indicated that a 1.4-kb product was
amplified from the dbpBA::Gentr strain and the genetically
complemented strain when primers 5ABmut and 3ABmut
were used, whereas a 1.6-kb fragment was obtained when the
same primers were used to amplify the native B. burgdorferi
dbpBA region of lp54 (Fig. 1A and 1B). A smaller faint band
was observed when the parent strain was used as the template,
but it was slightly below the 1.4-kb band obtained for the
dbpBA::Gentr strain. For the genetically complemented
strain both the 1.4- and 1.6-kb fragments were amplified, con-
sistent with the presence of dbpBA::Gentr and wild-type
dbpBA, respectively (Fig. 1A and 1B). As expected, primers
3pflgGentSal and 5pflgGentSal amplified a product only from
the mutant and genetically complemented strain, as did other
primer combinations that amplified sequences only from
strains carrying the dbpBA::Gentr allele (i.e., either primers
5ABmut and 5pflgGentSal or primers 3ABmut and 3pflgGent-
Sal), and the parent was negative for all of the PCRs when
these three primer pairs were used (Fig. 1A and 1B). Western
blot analysis confirmed that DbpA was not produced in the
isolates screened (Fig. 1C, compare lane 1 [parent] with lane 2
[dbpBA::Gentr]). Subsequent plasmid profile analysis indi-
cated that all of the dbpBA::Gentr clones obtained did not
contain the 9-kb circular plasmid (cp9) and lp25, like the par-
ent strain ML23 (31; data not shown). One clone, designated
JF105, was used for all subsequent analyses.
Genetic complementation of the dbpBA::Gentr mutant.
The genetic background used for isolation of dbpBA::Gentr
strain JF105 was ML23, which is a strain B31 derivative that is
missing lp25 (54). The lp25 plasmid is absolutely required for
survival in mammals due to the presence of the BBE22 gene,
which encodes a nicotinamidase essential for growth in these
hosts (46). In order to use this genetic background to deter-
mine how the loss of a specific gene affects B. burgdorferi
pathogenesis, the BBE22-containing region must be provided
in trans, as was done previously for the BBK32::Strr strain
JS315 (54). In addition, the genes that are inactivated or de-
leted need to be provided back for genetic complementation.
To facilitate this, the borrelial shuttle vector pBBE22, which
carries BBE22 and BBE23 (46), was modified with Invitrogen’s
Gateway system, which resulted in a plasmid backbone that
allowed efficient recombination of target genes in conjunction
with commercially available Gateway entry vectors. The result-
ing construct, designated pBBE22gate, was used to construct
plasmids carrying dbpBA with its native promoter region,
FIG. 1. Isolation and confirmation of dbpBA deletion mutants of in-
fectious B. burgdorferi. (A) Strategy for deleting dbpBA. Plasmid pNP3, in
which the BBA24 (dbpA) and BBA25 (dbpB) genes from lp54 were
replaced by the gentamicin resistance gene aacC1, was used to transform
B. burgdorferi strain B31 isolate ML23. Transformants were screened by
PCR using primers shown to confirm the dbpBA deletion. Arrows 1
through 4 represent oligonucleotide primers 5ABMut, 3ABMut,
3pflgGentSal, and 5pflgGentSal, respectively (Table 2). One isolate that
retained all plasmids (except cp9 and lp25) was obtained and designated
JF105. (B) PCR analysis of the dbpBA deletion mutant and comple-
mented strain. Lane 1, ML23/pBBE22 (parental strain); lane 2, JF105/
pBBE22 (dbpBA::Gentr); lane 3, JF105/pJBF17 (dbpBA::Gentr with
intact dbpBA). The primers used are indicated on the right (see panel A).
(C) Western blot analysis of the dbpBA::Gentr mutant and the geneti-
cally complemented strain. Samples were immunoblotted using antiserum
specific for DbpA. Lane 1, ML23/pBBE22 (parental strain); lane 2, JF105/
pBBE22 (dbpBA::Gentr); lanes 3 and 4, JF105/pJBF17 (dbpBA::Gentr
with intact dbpBA). Lanes 1 and 2 contained protein from 1 
 107
borrelial cells, while lanes 3 and 4 contained whole-cell equivalents from
1.25
 106 and 2.5
 106 organisms, respectively. The arrow indicates the
location of DbpA.
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which yielded plasmid pJBF17. Plasmids pBBE22 and pJBF17
were then separately transformed into JF105. Following selec-
tion, the transformants were screened by PCR, Southern blot-
ting, and plasmid profiling to ensure that the desired constructs
were obtained and that no additional loss of plasmids had
occurred (Fig. 1B and data not shown). The strains obtained
had the same plasmid profiles as their genetic parent (data not
shown). Furthermore, all the strains tested had similar growth
kinetics in BSK-II medium (data not shown). Subsequently,
immunoblot analysis was conducted to assess DbpA produc-
tion (Fig. 1C). Protein lysates were prepared for ML23/
pBBE22 (parental strain) (Fig. 1C, lane 1), JF105/pBBE22
(dbpBA::Gentr) (lane 2), and JF105/pJBF17 (dbpBA::Gentr
with intact dbpBA) (lanes 3 and 4). Lanes 1 and 2 contained
protein from 1 
 107 borrelial cells, while lanes 3 and 4 con-
tained whole-cell equivalents from 1.25 
 106 and 2.5 
 106
organisms, respectively, and were immunoblotted and probed
with antiserum specific for DbpA (Fig. 1C). The intensities of
the bands in lanes 1 and 3 are approximately the same, indi-
cating that genetic complementation of dbpBA on a borrelial
shuttle vector resulted in an approximately eightfold increase
in DbpA production. Serial dilutions of the dbpBA-comple-
mented samples indicated that the amounts of protein in these
samples were between four- and eightfold greater than the
amount of protein obtained with genomically encoded dbpA
(not shown), perhaps due to the increased copy number of the
shuttle vectors. Alternatively, the high copy number may have
altered the regulation of dbpBA by titrating out regulatory
proteins, resulting in the overproduction of DbpA. The latter
explanation seems unlikely given that the dbpBA genes are
regulated in a positive manner by borrelial RpoS (9, 25).
Deletion of dbpBA attenuates the infectivity potential of B.
burgdorferi. To determine how the dbpBA deletion affected B.
burgdorferi pathogenesis, immunocompetent C3H mice were
infected with 10-fold serial dilutions of JF105/pBBE22 (with
the dbpBA::Gentr deletion) and JF105/pJBF17 (the dbpBA-
complemented isolate), and the results were compared with
the results for mice infected with ML23/pBBE22 (the infec-
tious parent) in order to estimate the ID50 following 21 days of
infection (Table 3). The data indicated that the infectious
parent, ML23/pBBE22, which had an estimated ID50 of 150
organisms, exhibited infectivity similar to that of wild-type in-
fectious B. burgdorferi (31, 47). The ID50 for dbpBA::Gent
r
strain JF105/pBBE22 was more than 106 organisms, since no
tissues were culture positive for any of the mice infected with
102, 103, or 104 cells of the mutant and only 10 and 28% of the
tissues were culture positive for mice infected with 105 and 106
dbpBA::Gentr B. burgdorferi cells, respectively (Table 3). In
contrast, complementation with dbpBA restored the infectivity,
and the calculated ID50 was 316 organisms (Table 3). This
value is approximately twofold greater than the value for wild-
type infectious B. burgdorferi (Table 3). Interestingly, whereas
the positive-culture values for nearly all tissues were similar for
the parental and complemented strains, the complemented
strain exhibited an apparent defect in colonization of the
spleen (Table 3). Nevertheless, the results obtained clearly
indicate that the dramatic infectivity defect observed for the
dbpBA::Gentr B. burgdorferi strain is due to the lack of
DbpBA and not the result of polar effects, a secondary muta-
tion, or loss of an infectivity-associated plasmid. The infectivity
defect of the dbpBA::Gentr mutant observed in this study
following needle inoculation is in contrast to the results of the
initial study of Shi et al. (56), but it is in good agreement with
the results reported more recently by Shi et al. (55) and Blevins
et al. (4). Taken together, these results provide independent
corroboration that dbpBA is required for maximal infectivity in
the mouse model of experimental Lyme borreliosis following
needle inoculation.
To obtain a quantitative assessment of colonization, real-
time quantitative PCR was conducted. The results obtained
support the ID50 findings since the ability of B. burgdorferi
lacking dbpBA to colonize joint tissue following 21 days of
infection was significantly impaired compared to the abilities of
the infectious parent and complemented strain (P  0.0001
TABLE 3. ID50 of the dbpBA::Gent
r strain, JF105/pBBE22, in immunocompetent C3H mice
Isolate Inoculum(cells)
No. of cultures positive/total no. No. of mice
positive/total
no.
Calculated
ID50Lymph
node Skin
d Heart Spleen Bladder Joint All sites
ML23/pBBE22a 104 2/2 2/2 2/2 2/2 2/2 2/2 12/12 2/2 150e
103 4/4 4/4 4/4 4/4 4/4 4/4 24/24 4/4
102 1/3 1/3 1/3 1/3 1/3 1/3 6/18 1/3
JF105/pBBE22b 106 3/3 0/3 0/3 0/3 1/3 1/3 5/18 3/3 106
105 2/5 1/5 0/5 0/5 0/5 0/5 3/30 2/5
104 0/3 0/3 0/3 0/3 0/3 0/3 0/18 0/3
103 0/6 0/6 0/6 0/6 0/6 0/6 0/36 0/6
102 0/3 0/3 0/3 0/3 0/3 0/3 0/18 0/3
JF105/pJBF17c 105 2/3 3/3 3/3 2/3 3/3 3/3 16/18 3/3 316
104 3/3 2/3 3/3 0/3 3/3 3/3 14/18 3/3
103 4/5 4/5 4/5 0/5 4/5 4/5 20/30 4/5
102 2/3 0/3 1/3 1/3 1/3 1/3 6/18 2/3
a Parental strain B31 derivative which provides BBE22 in trans and is infectious (46).
b dbpBA::Gentr derivative of ML23/pBBE22.
c dbpBA::Gentr derivative of ML23/pBBE22 complemented with intact and expressed dbpBA.
d The skin tested was skin from the site of inoculation.
e The ID50 of ML23/pBBE22 is based on the results of numerous reproducible infectivity studies (31).
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and P  0.006, respectively) (Fig. 2). Specifically, all of the
joint samples from mice infected with 103 dbpBA::Gentr B.
burgdorferi cells were culture negative, and the bacteria were
not detected by quantitative PCR (Fig. 2). The number of B.
burgdorferi genomes obtained for the genetically comple-
mented strain in joint tissue was less than the number obtained
for the ML23/pBBE22 parent, and this may have reflected
incomplete complementation of the phenotype in this assay
(Table 3). Nevertheless, the quantitative PCR data support the
notion that the infectious potential of the dbpBA::Gentr mu-
tant is significantly reduced following 21 days of infection.
Infection of C3H-SCID mice with dbpBA::Gentr B. burg-
dorferi. A possible explanation for the clearance of the
dbpBA::Gentr mutant observed is that the adaptive immune
response results in rapid sterilization of the tissues coinciding
with the appearance of the immunoglobulin M response to B.
burgdorferi infection, as has been observed previously for a
mutant missing lp28-1 (30). Previously, Shi et al. reported that
SCID mice infected with 105 cells of B. burgdorferi having a
dbpBA deletion were completely infectious, supporting the hy-
pothesis that adaptive immunity is required for clearance of
this mutant (56). To determine how the absence of an adaptive
immune response impacted infectivity, we infected C3H-SCID
mice with either 103 or 105 cells of the infectious parent, the
dbpBA::Gentr mutant, or the dbpBA-complemented strain.
After 21 days the animals were sacrificed, and the tissues were
scored for the ability of B. burgdorferi to grow in BSK-II me-
dium. The results showed that after inoculation of 105 organ-
isms, there was effectively no difference in infectivity among
mice infected with the three strains, with the possible notable
exception of the results for the skin, which appeared to be
somewhat less efficiently colonized by the dbpBA::Gentr mu-
tant (Table 4). In contrast, when C3H-SCID mice were in-
fected with 103 spirochetes, the dbpBA::Gentr mutant could
not colonize the C3H-SCID mice in any tissue tested, whereas
the parent and genetically complemented strain colonized ev-
ery tissue (Table 4). These observations suggest that following
low-level infection (i.e., 103 spirochetes), the ability of the
dbpBA::Gentr mutant to survive in SCID mice is impaired in
a manner similar to that observed with immunocompetent
mice (Table 3) due to an inability to bind to host decorin
and/or to evade innate killing (compare the data for the 103-
cell inocula in Tables 3 and 4). Furthermore, adaptive immu-
nity is needed to effectively clear the dbpBA::Gentr mutant
following inoculation of large doses, as shown by the differen-
tial infectivity observed for immunocompetent and SCID mice
(Tables 3 and 4, respectively).
To quantify the B. burgdorferi present in C3H-SCID mouse
tissues, samples of the skin and joint tissue were analyzed using
quantitative PCR. The results indicate that the spirochetal
loads in the joints of C3H-SCID mice infected with infectious
B. burgdorferi cells were greater (approximately 10-fold
greater) (Fig. 3) than the spirochetal loads in the joints of
immunocompetent mice (Fig. 2), consistent with the idea that
an adaptive immune response is able to keep the infection in
check but does not clear B. burgdorferi from the tissues (Fig. 2).
Furthermore, the values obtained for the dbpBA::Gentr mu-
tant are consistent with the culture data obtained, because all
mice infected with 103 dbpBA::Gentr spirochetes were culti-
vation negative (Table 4) and based on quantitative PCR the
numbers of organisms were significantly less than the numbers
of cells of the parent and complemented strain (P 4 
 1014
FIG. 2. Quantitative real-time PCR analysis of the B. burgdorferi
parental (ML23/pBBE22), dbpBA::Gentr (JF105/pBBE22), and ge-
netically complemented (JF105/pJBF17) strains in joint tissue follow-
ing 21 days of infection in C3H mice. The absolute numbers of B.
burgdorferi cells obtained from joint tissue were determined using mice
infected with all three strains at a dose of 103 organisms. To normalize
for mouse tissue in each sample tested, the number of 	-actin copies
was also determined. The results are expressed as the number of B.
burgdorferi genome copies per 106 mouse 	-actin copies. P values are
indicated above the data.
TABLE 4. Infectivity of the dbpBA::Gentr strain in C3H-SCID mice
Isolate Inoculum(cells)
No. of cultures positive/total no.
No. of mice
positive/total no.Lymph
nodes Skin
a Heart Spleen Bladder Joint All sites
ML23/pBBE22 105 3/3 3/3 3/3 3/3 3/3 3/3 18/18 3/3
103 3/3 3/3 3/3 3/3 3/3 3/3 18/18 3/3
JF105/pBBE22 105 5/5 3/5 5/5 5/5 5/5 5/5 28/30 5/5
103 0/5 0/5 0/5 0/5 0/5 0/5 0/30 0/5
JF105/pJBF17 105 3/3 3/3 3/3 3/3 3/3 3/3 18/18 3/3
103 3/3 3/3 3/3 3/3 3/3 3/3 18/18 3/3
a The skin tested was skin from the site of inoculation.
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and P  5 
 1014, respectively) (Fig. 3A). In contrast, C3H-
SCID mice infected with 105 dbpBA::Gentr B. burgdorferi
cells were culture positive (Table 4), and spirochete genomes
were detectable in all five joint samples tested, although the
levels were lower than those of the infectious parent (however,
the difference was not statistically significant [P  0.4]) (Fig.
3A). As predicted, the colonization of the joint tissue of C3H-
SCID mice by the complemented strain was indistinguishable
from the colonization of the joint tissue of C3H-SCID mice by
the parent strain after inoculation of either a low or high dose
(P  0.65 and P  0.6, respectively) (Fig. 3A).
The efficiencies of colonization of the skin of C3H-SCID
mice by the parent and complemented strains were statistically
indistinguishable both when inocula containing 103 cells were
used and when inocula containing 105 cells were used (P 
0.65 and P  0.95, respectively) (Fig. 3B). As predicted by our
inability to culture dbpBA::Gentr B. burgdorferi from the skin
(or any other tissue) after injection of 103 organisms, quanti-
tative PCR of skin samples detected no bacteria, and the dif-
ferences were significant when the data were compared to data
for both the parent and complemented strains (P  1 
 104
and P  5 
 105, respectively) (Fig. 3B). After inoculation of
105 mutant bacteria, spirochete genomes were detectable in
the skin of three of five mice (Fig. 3B), which is in good
agreement with the culture data obtained (Table 4). Two of the
three positive skin samples contained inordinately high num-
bers of B. burgdorferi cells, but the reason for the variability is
not clear. Nevertheless, with the exception of these two
samples, all quantitative PCR values obtained for the
dbpBA::Gentr B. burgdorferi strain in joint tissue or skin, with
low or high doses, were lower than the values for the parent
and complemented strains, providing compelling evidence that
the ability of the dbpBA::Gentr strain to establish an infection
is impaired even in immunodeficient mice.
Kinetics of infection for dbpBA::Gentr B. burgdorferi. Since
the loss of dbpBA compromised the ability of B. burgdorferi to
colonize mice following 21 days of infection of immunocom-
petent mice, we wanted to determine both the temporal basis
and spatial basis of clearance. Also, since we determined that
adaptive immunity played a part in the clearance of the
dbpBA::Gentr mutant (Table 4), we were interested in assess-
ing colonization at earlier time points, when the innate im-
mune response may play a role in reducing the colonization of
the mutant. To this end, we performed a kinetics-based infec-
tivity experiment with either 103 or 105 cells of the parent, the
dbpBA::Gentr mutant, and the genetically complemented
strain using immunocompetent C3H mice. Following 12 h of
infection of immunocompetent C3H mice, lymph node tissue
was positive for one-half of the animals tested that were in-
fected with 103 B. burgdorferi cells irrespective of the strain
used; all other tissue sites tested (skin and spleen) were culture
negative for the 103-cell dose independent of the dbpBA status
of the samples tested (Table 5). For mice infected with 105
spirochetes, all strains tested colonized the site of intradermal
inoculation in all animals tested, and a disseminated infection
was also observed in most mice (50 to 70% of distant sites
depending on the strain tested [Table 5]). Thus, when culture
assays are used, the loss of dbpBA does not completely elimi-
nate the ability of B. burgdorferi to survive in mouse skin, as
well as other tissues, early in infection. However, at this point
we cannot exclude the possibility that the absolute numbers of
TABLE 5. Infectivity of the B. burgdorferi parental, dbpBA::Gentr,
and genetically complemented strains following 12 h of
infection in immunocompetent C3H mice
Isolate Inoculum(cells)
No. of cultures positive/total no. No. of mice
positive/
total no.
Lymph
nodes Skin
a Spleen All sites
ML23/pBBE22 105 4/5 5/5 3/5 12/15 5/5
103 3/5 0/5 0/5 3/15 3/5
JF105/pBBE22 105 4/5 5/5 3/5 12/15 5/5
103 2/5 0/5 0/5 2/15 2/5
JF105/pJBF17 105 3/5 5/5 2/5 10/15 5/5
103 2/4 0/4 0/4 2/12 2/4
a The skin tested was skin from the site of inoculation.
FIG. 3. Quantitative PCR to determine the absolute numbers of spi-
rochetes in joint tissue (A) and skin tissue (B) after 21 days of infection of
C3H-SCID mice by the B. burgdorferi parental, dbpBA::Gentr, and ge-
netically complemented strains at the inocula indicated. The results are
expressed as the number of B. burgdorferi genome copies per 106 mouse
	-actin copies. P values are indicated above the data sets that are being
compared.
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dbpBA::Gentr strain cells are much less than the absolute
numbers of cells of the infectious parent and the genetically
complemented strain.
When assays were performed over 21 days after inoculation
of 103 or 105 cells, the parent strain was capable of dissemi-
nating and persisting in all tissues tested. In contrast, at the low
dose (103 spirochetes), the dbpBA::Gentr mutant colonized
only one of five mice (in only three tissues) after 14 days. At
the higher dose (105 spirochetes), the mutant was capable of
dissemination, albeit impaired, in some of the mice, as shown
by the ability to culture borrelial cells lacking dbpBA from a
small minority of the tissues tested throughout the duration of
the kinetics experiment (Fig. 4). Specifically, the heart and
bladder were negative for all infections and at all time points
tested with the dbpBA::Gentr B. burgdorferi strain. Moderate
dissemination was observed in the spleen (1/5 sites positive
only at day 3), in the skin at the inoculation site (1/5 sites
positive only at day 21), and in the lymph nodes (3/5 and 2/5
sites positive at days 14 and 21) (Fig. 4). Interestingly, the joint
tissue was the tissue colonized best by the mutant, with 1/3, 1/3,
and 4/5 sites positive at days 5, 7, and 14, respectively. Al-
though the joint tissue of four of five mice was infected at day
14, none of these mice was still infected at day 21, indicating
that the dbpBA::Gentr B. burgdorferi strain that could colo-
nize this tissue was not able to persist, so no tissues were
culture positive by day 21 after low-dose infection and only a
small percentage of tissues were infected at this time point
following high-dose infection. Since our study ended at 21
days, we do not know if the organism in the sole skin sample
that became culture positive between days 14 and 21 could
persist or whether additional sites might become culture pos-
itive at a later time.
The colonization defects revealed in this kinetic study were
due to the dbpBA mutation, because the genetically comple-
mented strain (JF105/pJBF17) was, with few exceptions, capa-
ble of wild-type levels of colonization. In mice infected with 105
cells of the complemented strain there were dissemination and
nearly wild-type levels of persistence (Fig. 4). After adminis-
tration of a dose containing 103 cells, there was an apparent
decrease in colonization by the dbpBA-complemented strain
(JF105/pJBF17) at day 21, but this was due mostly to the
complete lack of infectivity in one of the five mice tested (Fig.
4). In addition, this kinetics experiment revealed that this
strain was cleared from the spleen between days 7 and 14,
consistent with our previous analysis of splenic colonization at
day 21 (Table 3). It is possible that the increased amount of
DbpBA produced by the genetically complemented strain re-
sulted in clearance due to enhanced binding of antiserum
against DbpA and DbpB, as proposed by Xu et al. (62). The
slight differences between the parental and complemented
strains aside, taken together, the results indicate that a B.
burgdorferi strain lacking DbpBA was able to disseminate in
some of the mice infected, but to a markedly reduced extent,
and, more importantly, that the ability of this strain to persis-
tently infect immunocompetent mice was greatly impaired.
DISCUSSION
As the first step in successful infection of a host, a pathogen
must bind to host structures and either replicate and dissemi-
FIG. 4. Kinetics of B. burgdorferi dissemination in C3H mice. C3H mice were infected with the B. burgdorferi parental, dbpBA::Gentr, and
genetically complemented strains using 103 spirochetes, and the dbpBA::Gentr and genetically complemented strains were also infected using 105
organisms. Mice were sacrificed on days 3, 5, 7, 14, and 21, and the tissues were cultured to determine B. burgdorferi growth. The strains and doses
tested are indicated below the x axis. The percentages of culture-positive samples are indicated on the y axis. The results are expressed as
percentages of culture-positive samples for the strains and concentrations of spirochetes tested. The values represent data for three to six mice
depending on the strain and time point evaluated. An asterisk indicates that all samples tested were culture negative. LN, lymph nodes.
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nate from the binding site or subsequently invade host cells.
For either extracellular or intracellular pathogens, successful
colonization requires an ability to replicate and disseminate to
peripheral sites or to infect adjacent cells or tissues, after which
a secondary colonization step can occur. In the case of B.
burgdorferi, deposition in the dermis of a mammal resulting
from the bite of an infected tick introduces the pathogen to a
number of potential binding substrates in this locale, most
notably ECM proteoglycan ligands.
Previous biochemical studies demonstrated that B. burgdor-
feri can bind to several host structures found in the ECM,
including decorin and fibronectin, and on host cells, including
integrin receptors, glycosoaminoglycans, and surface-associ-
ated factor H, via the activity of DbpA, DbpB, BBK32, P66,
Bgp, and factor H binding proteins (6, 12, 14, 19–21, 23, 27, 28,
33, 38, 41, 42, 44, 45, 49, 54). Accordingly, it has long been
argued that adherence to these sites is a key step in borrelial
pathogenesis (for reviews, see references 8 and 13). However,
until recently, it was difficult to assess the role of a particular
gene or its product in borrelial pathogenesis due to an inability
to genetically manipulate B. burgdorferi. Recently, many differ-
ent investigators have independently developed methodologies
to isolate and characterize isogenic mutants of infectious B.
burgdorferi strains, and, with the advent of these advances (for
a review, see reference 50), several borrelial adhesins have
been inactivated and their effects on the resulting virulence
have been examined. Specifically, isogenic dbpBA, BBK32, and
bgp mutants of infectious B. burgdorferi strains have been iso-
lated (42, 54–56). A p66 mutant has been obtained only in a
noninfectious background (12), so its role in borrelial patho-
genesis is not known yet. Knockout of bgp had no effect on B.
burgdorferi virulence when the organism was assayed using
immunodeficient mice (42), whereas the BBK32 mutant exhib-
ited only a slight infectivity defect (54). The lack of a dramatic
phenotype for either the bgp or BBK32 mutant implies that
other adhesins may compensate for the known binding prop-
erties of the bgp and BBK32 proteins or that these molecules
play a subtle role in the pathogenesis of B. burgdorferi. With
regard to compensatory function, the ability to bind to glyco-
soaminoglycans has been reported for Dbp proteins, Bgp, and
BBK32 (8, 13, 18, 19, 41, 42). Thus, if the binding to a given
adhesin is directed primarily against a glycosoaminoglycan
structure, then inactivation of such a gene (e.g., bgp) may have
a more subtle effect on borrelial pathogenesis.
For dbpBA, recent publications from one laboratory sug-
gested (i) that DbpA and DbpB were not essential for infection
in immunocompetent mice, (ii) that overexpression of dbpA
increased the infectivity of B. burgdorferi, and (iii) that DbpB
and DbpBA were required for full virulence of B. burgdorferi
following needle inoculation (55, 56, 62). To reconcile these
apparently disparate observations, we examined how the loss
of DbpBA affects the ability of B. burgdorferi to colonize C3H
mice by calculating an ID50 and performing a kinetics-based
infectivity analysis.
Our results clearly showed that deletion of dbpBA attenuates
the pathogenic potential of B. burgdorferi based on ID50 analyses
after 21 days of infection following needle inoculation (Table 3),
which independently corroborated the results most recently re-
ported by Shi et al. (55) and Blevins et al. (4). Specifically, the
dbpBA::Gentr strain was isolated from only 10 and 28% of the
sites when inocula containing 105 and 106 spirochetes, respec-
tively, were used and from no tissue sample when inocula con-
taining fewer spirochetes were used (Table 3). In addition, genetic
complementation of the dbpBA::Gentr strain (JF105/pBBE22)
with intact dbpBA (JF105/pJBF17) restored infectivity in mice in
most instances, indicating that the infectivity defect observed in
the dbpBA::Gentr strain was due to the deletion of dbpBA and
not the result of polar effects, an unlinked mutation, or loss of an
infectivity-associated plasmid from B. burgdorferi (Table 3). Fi-
nally, the quantitative real-time PCR analysis corroborated the
infectivity data for immunocompetent mice as thedbpBA::Gentr
B. burgdorferi strain was not detected in joints when an inoculum
containing 103 organisms was used. Conversely, analysis of the
parent and dbpBA-complemented strain samples showed that
there was ample B. burgdorferi in the joint tissues tested, although
the levels for the complemented strain samples were lower than
the levels for the parent strain samples (Fig. 2). Taken together,
these results indicate that DbpA and/or DbpB is required for
maximal infectivity in the mouse model following 21 days of
infection.
Because the dbpBA::Gentr strain has such a dramatic phe-
notype, we were interested in determining the temporal and
spatial basis of clearance of this strain. The kinetics-based
analysis indicated that, particularly after a high-dose intrader-
mal inoculum was used, the dbpBA::Gentr strain was able to
disseminate to several tissues, including the joint tissue, in four
of five of the mice infected after 14 days but was unable to
maintain a persistent infection (Fig. 4). The inability of the
dbpBA::Gentr strain to maintain an infection might be ex-
plained by two possible mechanisms that are not mutually
exclusive. First, the inability of the dbpBA::Gentr strain to
bind to host decorin could result in more efficient clearance of
the mutant from the host. Although unproven, it is conceivable
that the lack of binding to host decorin results in free-floating
dbpBA::Gentr cells in interstitial fluid in the skin that are
more readily phagocytosed by innate immune cells. Previously,
Liang et al. reported that the interaction of B. burgdorferi with
host decorin protected the spirochete from clearance, presum-
ably due to the inability of antibodies directed against the
borrelial Dbp proteins to bind to and eliminate the spirochete
(34). This may be an important factor in the inability of the
dbpBA::Gentr mutant to persist, but it does not explain
the rapid clearance of the mutant from the infected mice
before adaptive immune mechanisms clear the organism. Thus,
the second possibility is that the Dbp proteins provide a mech-
anism to override the initial innate immune response, which
allows the spirochete to disseminate and remain infective. The
exact mechanism used by the Dbp proteins is not known, but it
may involve interactions with other host proteins that alter the
immunological response to favor borrelial colonization and
persistence.
Previously, Brown et al. reported that decorin-deficient mice
(Dcn/) exhibited a reduction in B. burgdorferi colonization,
particularly at low doses (7). In the subsequent study of Liang
et al., when the size of the B. burgdorferi inoculum was in-
creased, few differences between wild-type and decorin-defi-
cient mice were observed except for the joint and skin, where
in the decorin-deficient mice there was reduced colonization
following 2 weeks of infection (34). Interestingly, the numbers
for the skin and joint tissue were significantly reduced follow-
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ing 2 months of infection compared to the data for the Dcn/
mice, suggesting that the organisms might localize to different
sites in wild-type and Dcn/ mice and/or that the adaptive
immune response is able to process B. burgdorferi more effi-
ciently in the Dcn/ mice (34).
Although the infectivity of B. burgdorferi was reduced in the
Dcn/ mice, B. burgdorferi was able to colonize the decorin-
deficient mice with most of the inocula tested (7). The striking
difference in infectivity observed for the dbpBA::Gentr strain
reported here compared to the results for the decorin-deficient
mice implies that DbpA and DbpB may have additional roles
in borrelial pathogenesis over and above their adherence ac-
tivity with host decorin. If adherence to decorin were the only
function attributable to DbpA and DbpB, then the infectivity
phenotype for decorin-deficient mice and wild-type B. burgdor-
feri and the infectivity phenotype for wild-type mice and the
dbpBA::Gentr B. burgdorferi strain should be comparable.
The difference observed suggests that Dbp proteins may affect
the host response to B. burgdorferi infection. Alternatively, as
indicated above, it is possible that the inability of the
dbpBA::Gentr strain to bind decorin puts the B. burgdorferi
cells at greater risk of being phagocytosed by innate immune
cells. Studies to examine these possibilities are under way.
It is highly likely that the innate and adaptive immune re-
sponses are both involved in the clearance of the dbpBA::Gentr
isolate, as shown by the SCID mouse infectivity data (Table 4 and
Fig. 3). Specifically, whereas the low-dose inoculum of the
dbpBA::Gentr strain tested (103 organisms) was cleared in SCID
mice, infection of SCID mice by the parent strain and by the
genetically complemented strain was indistinguishable from in-
fection of immunocompetent mice by these strains based on the
culture-positive phenotype (Table 4). This is in stark contrast to
the results for complete infection of SCID mice with 105 organ-
isms independent of the status of the dbpBA genes, suggesting
that clearance of the dbpBA::Gentr strain in immunocompetent
mice is also dependent on the adaptive immune response (Table
4). Previously, Shi et al. showed that SCID mice infected by the
dbpBA mutant were indistinguishable from SCID mice infected
by the infectious parent, but these workers evaluated only infec-
tions with 105 B. burgdorferi cells (56). With only data for this high
dose, one might erroneously conclude that one function of Db-
pBA is to avoid clearance by adaptive immunity. If adaptive
immunity were the sole immune clearance mechanism, then the
dbpBA::Gentr mutant would disseminate to all tissues, with
clearance initiated when borrelia-specific antibodies are gener-
ated, as was observed for B. burgdorferi cells lacking lp28-1 (30).
The enhanced clearance of the dbpBA::Gentr strain suggests
that decorin binding and/or the binding to other host factors via
the Dbp proteins protects the spirochetes from rapid clearance
via innate immune cells, presumably resident macrophages, lang-
erhans cells, and/or neutrophils. Alternatively, the loss of Dbp
proteins from the surface of B. burgdorferi may put the spirochetes
at risk since high levels of DbpA and DbpB would likely be
produced during infection. Thus, the loss of an abundant surface
protein may compromise the overall integrity of the borrelial
outer membrane and lead to enhanced innate immune clearance,
as recently proposed by Xu et al. (61).
Recently, Blevins et al. reported that a dbpBA deletion mu-
tant of strain 297 was severely defective for infectivity following
needle inoculation of immunocompetent mice (4), similar to
the infectivity results presented here. Interestingly, the strain
297 mutant did not exhibit as dramatic a phenotype when the
infection was initiated using infected ticks. While one possible
interpretation of these findings is that the DbpA and DbpB
proteins do not play an important role during mammalian
infection (contrary to conclusions based on needle inoculation
studies), it is also possible that some defect in the infectivity of
a dbpBA mutant after tick inoculation might be revealed upon
further investigation. For example, whereas 100% (two of two)
of mice that were infected using 5 ticks containing the parental
strain became infected, 50% (one of two) and 67% (four of six)
of mice that were infected using 5 and 10 ticks containing the
dbpBA mutant, respectively, became infected. It is also not
clear whether the 297 dbpBA mutant was capable of dissemi-
nated infection following tick infection since the infectivity of
tick-infected mice was evaluated only by testing ear skin at a
site presumably adjacent to where the tick feeding occurred.
Finally, if in fact DbpA and DbpB play a less critical role after
tick inoculation than after needle inoculation, the results may
reflect the ability of tick saliva to locally immunosuppress the
host immune response (3, 24, 29, 32) such that the B. burgdor-
feri dbpBA deletion strain deposited in the skin can migrate to
immunoprotected niches in the skin, which are then protected
against subsequent clearance by the adaptive immune re-
sponse. This explanation is consistent with the data that we
obtained with SCID mice, which showed that a dbpBA deletion
mutant can colonize immunodeficient mice when higher doses
are used (Table 4).
In summary, we showed that loss of the dbpBA genes results
in a dramatic loss of infectivity in the mouse model of exper-
imental Lyme disease. Furthermore, kinetics analyses indi-
cated that B. burgdorferi cells that do not synthesize DbpBA
exhibit muted dissemination when high-dose inocula are used
and are unable to persist. The ability of SCID mice to clear the
B. burgdorferi dbpBA::Gentr strain when low doses were used
suggests that the DbpBA proteins are required for early sur-
vival due to binding to host decorin, which may provide a
microenvironment that prevents innate immune clearance in a
manner reminiscent of tick-based infectivity, where the tick
saliva may locally immunosuppress the host response (3, 24, 29,
32). As indicated above, this may explain the difference be-
tween the infectivity potential observed for ticks and the in-
fectivity potential observed for needle inoculation, where the
dbpBA mutant was able to colonize mice following a blood
meal (4). Nevertheless, the results presented here extend pre-
viously reported data by demonstrating that dbpBA::Gentr
cells are cleared early during the infectious process in immu-
nocompetent and SCID mice. The number of cells that are
capable of surviving in immunocompetent mice is then greatly
reduced when the host mounts a borrelia-specific adaptive
immune response. In addition, these studies provided indepen-
dent corroboration of the conclusion that the dbpBA genes are
important for the maximum pathogenic potential of B. burg-
dorferi following needle inoculation (55, 56). Finally, the large
difference between the infection potential of wild-type B. burg-
dorferi in decorin-deficient mice (7) and the infection potential
of the dbpBA::Gentr deletion strain in wild-type mice shown
here suggests that, in addition to their role in binding host
decorin, the Dbp proteins may modulate the host immune
response through interaction with additional host structures in
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a manner that allows B. burgdorferi to establish and maintain
an infection.
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